← Leaderboards
Yuri Persidsky
Temple Univ Of The Commonwealth
$27,976,914
Attributed
$36,231,643
Total exposure
16
Grants
11
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.2M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$36,231,643 · 16
By mechanism
R01$28,335,130 · 10
R37$3,575,021 · 1
U01$1,755,000 · 1
P01$1,480,092 · 2
R21$882,000 · 1
R29$204,400 · 1
Top collaborators
- Thomas J Rogers10 shared
- James Haorah8 shared
- Anuja Ghorpade5 shared
- Kelly L Jordan-Sciutto5 shared
- Servio Heybert Ramirez5 shared
Most similar at Temple Univ Of The Commonwealth
Same institution · by research overlap
- Servio Heybert Ramirez$5,873,481
Others in their field
Top investigators on “Neuroinflammation”
- Gareth R Howell · Jackson Laboratory$39,730,203
- James J Lah · Emory University$36,316,355
- Robert O Wright · Brigham And Women'S Hospital$26,477,749
- Rosalind J Wright · Icahn School Of Medicine At Mount Sinai$26,477,749
- Howard Feldman · University Of California, San Diego$26,252,137
- Katerina Akassoglou · University Of California San Diego$19,825,589
Research focus
NeuroinflammationMonocyteBrainBlood - Brain Barrier AnatomyIn VivoChronicInflammatoryCellsMacrophageEndotheliumMigrationIn VitroResponseAnimal ModelProteinsInjuryMediatingTight JunctionsMicrogliaFunctional DisorderCytokinePreventEncephalitisInflammation
Grant awards (89)
Injury of blood brain and alveolar-endothelial barriers caused by alcohol and electronic cigarettes via purinergic receptor signaling$574,030
R01 · FY2025 · AA · contact PI
The role of cannabinoids in the regulation of the blood brain barrier in the context of NeuroHIV and anti-retroviral therapy$571,118
R01 · FY2025 · DA · contact PI
Injury of blood brain and alveolar-endothelial barriers caused by alcohol and electronic cigarettes via purinergic receptor signaling$608,357
R01 · FY2024 · AA · contact PI
The role of cannabinoids in the regulation of the blood brain barrier in the context of NeuroHIV and anti-retroviral therapy$604,910
R01 · FY2024 · DA · contact PI
Inflammation associated with HIV infection: role of receptor cross-talk$657,060
R01 · FY2023 · DA
The role of cannabinoids in the regulation of the blood brain barrier in the context of NeuroHIV and anti-retroviral therapy$604,910
R01 · FY2023 · DA
Injury of blood brain and alveolar-endothelial barriers caused by alcohol and electronic cigarettes via purinergic receptor signaling$594,907
R01 · FY2023 · AA · contact PI
Inflammation associated with HIV infection: role of receptor cross-talk$657,060
R01 · FY2022 · DA
The role of cannabinoids in the regulation of the blood brain barrier in the context of NeuroHIV and anti-retroviral therapy$611,409
R01 · FY2022 · DA
Blood brain barrier injury in HIV infection complicated by diabetes: Mechanisms and protective strategies preventing cognitive impairment$502,493
R01 · FY2022 · MH · contact PI
Inflammation associated with HIV infection: role of receptor cross-talk$657,060
R01 · FY2021 · DA
The role of cannabinoids in the regulation of the blood brain barrier in the context of NeuroHIV and anti-retroviral therapy$599,712
R01 · FY2021 · DA
Blood brain barrier injury in HIV infection complicated by diabetes: Mechanisms and protective strategies preventing cognitive impairment$508,199
R01 · FY2021 · MH · contact PI
Inflammation associated with HIV infection: role of receptor cross-talk$645,154
R01 · FY2020 · DA
Blood brain barrier injury in HIV infection complicated by diabetes: Mechanisms and protective strategies preventing cognitive impairment$525,220
R01 · FY2020 · MH · contact PI
HIV-induced neuroinflammation associated with opiod abuse and tobacco smoke$434,132
R01 · FY2020 · DA
Novel CB2 agonists shield brain from HIV infection and alcohol exposure$351,000
U01 · FY2020 · AA · contact PI
HIV-induced neuroinflammation associated with opiod abuse and tobacco smoke$661,297
R01 · FY2019 · DA
Inflammation associated with HIV infection: role of receptor cross-talk$660,078
R01 · FY2019 · DA
Secoisolariciresinol diglucoside to mitigate inflammation and toxicity in HAND$588,356
R01 · FY2019 · MH
Blood brain barrier injury in HIV infection complicated by diabetes: Mechanisms and protective strategies preventing cognitive impairment$538,058
R01 · FY2019 · MH · contact PI
CNS injury caused by HIV-1 and alcohol: Protective effects of CB2 activation$370,369
R37 · FY2019 · AA · contact PI
Novel CB2 agonists shield brain from HIV infection and alcohol exposure$351,000
U01 · FY2019 · AA · contact PI
HIV-induced neuroinflammation associated with opioid abuse and tobacco smoke$658,459
R01 · FY2018 · DA
Secoisolariciresinol diglucoside to mitigate inflammation and toxicity in HAND$586,702
R01 · FY2018 · MH
Blood brain barrier injury in HIV infection complicated by diabetes: Mechanisms and protective strategies preventing cognitive impairment$455,369
R01 · FY2018 · MH · contact PI
CNS injury caused by HIV-1 and alcohol: Protective effects of CB2 activation$370,369
R37 · FY2018 · AA · contact PI
Novel CB2 agonists shield brain from HIV infection and alcohol exposure$351,000
U01 · FY2018 · AA · contact PI
HIV-induced neuroinflammation associated with opiod abuse and tobacco smoke$761,723
R01 · FY2017 · DA
Secoisolariciresinol diglucoside to mitigate inflammation and toxicity in HAND$642,076
R01 · FY2017 · MH
CNS injury caused by HIV-1 and alcohol: Protective effects of CB2 activation$370,369
R37 · FY2017 · AA · contact PI
Novel CB2 agonists shield brain from HIV infection and alcohol exposure$351,000
U01 · FY2017 · AA · contact PI
HIV-induced neuroinflammation associated with opiod abuse and tobacco smoke$733,470
R01 · FY2016 · DA
Secoisolariciresinol diglucoside to mitigate inflammation and toxicity in HAND$654,687
R01 · FY2016 · MH
BBB Protection in HIV Infection: Barrier-shielding effects of PARP inhibition$458,846
R01 · FY2016 · MH · contact PI
CNS injury caused by HIV-1 and alcohol: Protective effects of CB2 activation$370,369
R37 · FY2016 · AA · contact PI
Novel CB2 agonists shield brain from HIV infection and alcohol exposure$351,000
U01 · FY2016 · AA · contact PI
Secoisolariciresinol diglucoside to mitigate inflammation and toxicity in HAND$803,793
R01 · FY2015 · MH
BBB Protection in HIV Infection: Barrier-shielding effects of PARP inhibition$458,846
R01 · FY2015 · MH · contact PI
CNS injury caused by HIV-1 and alcohol: Protective effects of CB2 activation$370,369
R37 · FY2015 · AA · contact PI
BBB Protection in HIV Infection: Barrier-shielding effects of PARP inhibition$458,846
R01 · FY2014 · MH · contact PI
CNS injury caused by HIV-1 and alcohol: Protective effects of CB2 activation$338,797
R37 · FY2014 · AA · contact PI
BBB Protection in HIV Infection: Barrier-shielding effects of PARP inhibition$440,492
R01 · FY2013 · MH · contact PI
Mechanisms and Interventions for Methamphetamine and HIV-1 Induced CNS Injury$375,392
R01 · FY2013 · DA · contact PI
CNS injury caused by HIV-1 and alcohol: Protective effects of CB2 activation$324,827
R37 · FY2013 · AA · contact PI
BBB Protection in HIV Infection: Barrier-shielding effects of PARP inhibition$495,775
R01 · FY2012 · MH · contact PI
Mechanisms and Interventions for Methamphetamine and HIV-1 Induced CNS Injury$392,989
R01 · FY2012 · DA · contact PI
CNS injury caused by HIV-1 and alcohol: Protective effects of CB2 activation$349,276
R37 · FY2012 · AA · contact PI
Alcohol Abuse and HIV-1: Mechanisms of Combined CNS Injury and Interventions$12,240
R01 · FY2012 · AA · contact PI
BBB Protection in HIV-1 Dementia: Anti-Inflammatory effects of GSK-3beta suppres$419,181
R01 · FY2011 · MH · contact PI
Mechanisms and Interventions for Methamphetamine and HIV-1 Induced CNS Injury$394,978
R01 · FY2011 · DA · contact PI
CNS injury caused by HIV-1 and alcohol: Protective effects of CB2 activation$349,276
R37 · FY2011 · AA · contact PI
Alcohol Abuse and HIV-1: Mechanisms of Combined CNS Injury and Interventions$319,235
R01 · FY2011 · AA · contact PI
Alcohol Abuse and HIV-1: Mechanisms of Combined CNS Injury and Interventions$69,745
R01 · FY2011 · AA · contact PI
BBB Protection in HIV-1 Dementia: Anti-Inflammatory effects of GSK-3beta suppres$423,418
R01 · FY2010 · MH · contact PI
Mechanisms and Interventions for Methamphetamine and HIV-1 Induced CNS Injury$397,160
R01 · FY2010 · DA · contact PI
CNS injury caused by HIV-1 and alcohol: Protective effects of CB2 activation$361,000
R37 · FY2010 · AA · contact PI
Alcohol Abuse and HIV-1: Mechanisms of Combined CNS Injury and Interventions$332,121
R01 · FY2010 · AA · contact PI
BBB Protection in HIV-1 Dementia: Anti-Inflammatory effects of GSK-3beta suppres$421,788
R01 · FY2009 · MH · contact PI
Mechanisms and Interventions for Methamphetamine and HIV-1 Induced CNS Injury$398,232
R01 · FY2009 · DA · contact PI
Alcohol Abuse and HIV-1: Mechanisms of Combined CNS Injury and Interventions$335,475
R01 · FY2009 · AA · contact PI
PPAR-gamma-mediated neuroprotection against HIV-1 and alcohol CNS injury$320,012
R01 · FY2009 · AA · contact PI
Macrophage, blood-brain barrier, and modulation of neurodegeneration$253,567
P01 · FY2009 · NS · contact PI
PPAR-gamma-mediated neuroprotection against HIV-1 and alcohol CNS injury$16,200
R01 · FY2009 · AA · contact PI
Alcohol Abuse and HIV-1: Mechanisms of Combined CNS Injury and Interventions$10,000
R01 · FY2009 · AA · contact PI
BBB Protection in HIV-1 Dementia: Anti-Inflammatory effects of GSK-3beta suppres$412,880
R01 · FY2008 · MH · contact PI
Alcohol Abuse and HIV-1: Mechanisms of Combined CNS Injury and Interventions$347,975
R01 · FY2008 · AA · contact PI
PPAR-gamma-mediated neuroprotection against HIV-1 and alcohol CNS injury$313,611
R01 · FY2008 · AA · contact PI
Macrophage, blood-brain barrier, and modulation of neurodegeneration$235,200
P01 · FY2008 · NS · contact PI
BBB Protection in HIV-1 Dementia: Anti-Inflammatory effects of GSK-3beta suppres$449,525
R01 · FY2007 · MH · contact PI
Alcohol Abuse and HIV-1: Mechanisms of Combined CNS Injury and Interventions$330,750
R01 · FY2007 · AA · contact PI
PPAR-gamma-mediated neuroprotection against HIV-1 and alcohol CNS injury$313,611
R01 · FY2007 · AA · contact PI
Microglial Deactivation and HIV Dementia: Logical Therapy$189,585
P01 · FY2007 · NS · contact PI
PPAR-gamma-mediated neuroprotection against HIV-1 and alcohol CNS injury$322,978
R01 · FY2006 · AA · contact PI
BBB Tight Junctions During HIV-1 dementia$286,030
R01 · FY2006 · MH · contact PI
Microglial Deactivation and HIV Dementia$199,945
P01 · FY2006 · NS · contact PI
PPAR-gamma-mediated neuroprotection against HIV-1 and alcohol CNS injury$330,750
R01 · FY2005 · AA
BBB Tight Junctions During HIV-1 dementia$294,000
R01 · FY2005 · MH
Microglial Deactivation and HIV Dementia$200,485
P01 · FY2005 · NS
Effect of Alcohol on HIV-1 Immune Responses &BBB Damage$294,000
R21 · FY2004 · AA
BBB Tight Junctions During HIV-1 dementia$294,000
R01 · FY2004 · MH
Microglial Deactivation and HIV Dementia$200,655
P01 · FY2004 · NS
BBB Tight Junctions During HIV-1 dementia$294,000
R01 · FY2003 · MH
Effect of Alcohol on HIV-1 Immune Responses &BBB Damage$294,000
R21 · FY2003 · AA
Microglial Deactivation and HIV Dementia$200,655
P01 · FY2003 · NS
BBB Tight Junctions During HIV-1 dementia$294,250
R01 · FY2002 · MH
Effect of Alcohol on HIV-1 Immune Responses &BBB Damage$294,000
R21 · FY2002 · AA
BIOLOGICAL BASIS FOR HIV1 NEUROVIRULENCE$102,200
R29 · FY2001 · AI
BIOLOGICAL BASIS FOR HIV1 NEUROVIRULENCE$102,200
R29 · FY2000 · AI